Samrat Pharmachem Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
---|---|---|---|
Revenue | 76.34 | 71.10 | 63.67 |
Operating Expense | 75.53 | 71.08 | 59.49 |
Net Profit | -0.23 | -0.40 | 2.78 |
Net Profit Margin | -0.30 | -0.56 | 4.37 |
Earning Per Share | -0.74 | -1.29 | 9.01 |
EBIDTA | 0.38 | 0.07 | 3.93 |
Effective Tax Rate | TBA | 450 | 21.05 |
Particulars | Jun 2025 |
---|---|
Revenue | 76.34 |
Operating Expense | 75.53 |
Net Profit | -0.23 |
Net Profit Margin | -0.30 |
Earning Per Share | -0.74 |
EBIDTA | 0.38 |
Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Total Revenue Annual | 285.86 | 281.58 | 310.65 |
Operating Expenses Annual | 275.62 | 279.11 | 286.72 |
Operating Profit Annual | 11.21 | 3.85 | 24.41 |
Interest Annual | 0.67 | 0.69 | 1.23 |
Depreciation | 0.65 | 0.65 | 0.64 |
Net Profit Annual | 7.11 | 2.16 | 16.63 |
Tax Annual | 2.77 | 0.36 | 5.90 |
Particulars | Mar 2025 |
---|---|
Total Revenue Annual | 285.86 |
Operating Expenses Annual | 275.62 |
Operating Profit Annual | 11.21 |
Interest Annual | 0.67 |
Depreciation | 0.65 |
Net Profit Annual | 7.11 |
Tax Annual | 2.77 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Cash Flow at the Beginning | 9.67 | 11.86 | 14.71 |
Cash Flow from Operations | -10.09 | 9.41 | -9.44 |
Cash Flow from Investing | TBA | -0.41 | -3 |
Cash Flow from Financing | 0.48 | -11.20 | 9.60 |
Cash Flow at the End | 0.05 | 9.67 | 11.86 |
Particulars | Mar 2025 |
---|---|
Cash Flow at the Beginning | 9.67 |
Cash Flow from Operations | -10.09 |
Cash Flow from Investing | TBA |
Cash Flow from Financing | 0.48 |
Cash Flow at the End | 0.05 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
PBDIT Margin (%) | 3.92 | 1.01 | 7.85 |
PBIT Margin (%) | 3.69 | 0.78 | 7.65 |
PBT Margin (%) | -1.82 | -0.35 | 1.43 |
Net PROFIT Margin (%) | 2.49 | 0.77 | 5.35 |
Return On Networth / Equity (%) | 10.39 | 1.98 | 30.25 |
Return On Networth /Employed (%) | 13.60 | 2.83 | 34.91 |
Return On Assets (%) | 9.15 | 2.78 | 24.41 |
Total Debt / Equity (X) | 0.13 | 0.21 | 0.24 |
Asset Turnover Ratio (%) | 3.68 | 3.63 | 4.56 |
Particulars | Mar 2025 |
---|---|
PBDIT Margin (%) | 3.92 |
PBIT Margin (%) | 3.69 |
PBT Margin (%) | -1.82 |
Net PROFIT Margin (%) | 2.49 |
Return On Networth / Equity (%) | 10.39 |
Return On Networth /Employed (%) | 13.60 |
Return On Assets (%) | 9.15 |
Total Debt / Equity (X) | 0.13 |
Asset Turnover Ratio (%) | 3.68 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Fixed Assets Annual | 10.48 | 10.72 | 10.70 |
Total Current Assets Annual | 103.36 | 102.57 | 99.05 |
Non Current Assets Annual | 18.13 | 19.17 | 17.54 |
Total Shareholders Funds Annual | 71.80 | 65.00 | 63.14 |
Total Assets Annual | 121.49 | 121.74 | 116.59 |
Particulars | Mar 2025 |
---|---|
Fixed Assets Annual | 10.48 |
Total Current Assets Annual | 103.36 |
Non Current Assets Annual | 18.13 |
Total Shareholders Funds Annual | 71.80 |
Total Assets Annual | 121.49 |
No Data Availabe